NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patientsSunny Malhotra, Manuel Comabella, Eduard Sarró et al.|Brain|2020Cited by 136
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Manuel Comabella, Begoña Oliver‐Martos et al.|Brain|2015Cited by 110